5-(3-hydroxyphenyl)-5-phenylhydantoin and Parkinson Disease

5-(3-hydroxyphenyl)-5-phenylhydantoin has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bloem, BR; de Wolff, FA; Ferrari, MD; Kuiper, MA; Peeters, EA; Roos, RA; Vermeij, P; Wolters, EC	1

Other Studies

1 other study(ies) available for 5-(3-hydroxyphenyl)-5-phenylhydantoin and Parkinson Disease

Article	Year
Phenytoin parahydroxylation is not impaired in patients with young-onset Parkinson's disease. Clinical neurology and neurosurgery, 1994, Volume: 96, Issue:4 Topics: Administration, Oral; Adult; Age Factors; Cytochrome P-450 Enzyme System; Female; Humans; Hydroxylation; Inactivation, Metabolic; Isoenzymes; Male; Metabolic Clearance Rate; Middle Aged; Parkinson Disease; Phenytoin; Reference Values	1994

Article

Year

Phenytoin parahydroxylation is not impaired in patients with young-onset Parkinson's disease.

Clinical neurology and neurosurgery, 1994, Volume: 96, Issue:4

Topics: Administration, Oral; Adult; Age Factors; Cytochrome P-450 Enzyme System; Female; Humans; Hydroxylation; Inactivation, Metabolic; Isoenzymes; Male; Metabolic Clearance Rate; Middle Aged; Parkinson Disease; Phenytoin; Reference Values

1994